Showing results (581-590 of 611) with videos related to

Sort By:
Pageof 62
Biorxiv : the Preprint Server for Biology|April 10, 2026
Thalamocortical network dynamics in focal epilepsy: SEEG investigationElliot M Nester, Maya A Jayaram, Tejas Umesh, et al.
American Journal of Nephrology|November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor DanicopanSteven D Podos, Howard Trachtman, Gerald B Appel, et al.
Pediatric Blood & Cancer|May 22, 2024
Prevention of treatment abandonment remains an important challenge to increase survival of Wilms tumor in sub-Saharan Africa: A report from Wilms Africa-CANCaRe AfricaBarnabas Atwiine, Cecilia Mdoka, Mushabe Branchard, et al.
Kidney International Reports|December 18, 2023
Efficacy and Safety of Iptacopan in Patients With C3 GlomerulopathyEdwin Wong, Carla Nester, Teresa Cavero, et al.
Pediatric Nephrology (Berlin, Germany)|April 11, 2015
An international consensus approach to the management of atypical hemolytic uremic syndrome in childrenChantal Loirat, Fadi Fakhouri, Gema Ariceta, et al.
Applied and Environmental Microbiology|December 18, 2012
Reconciliation of sequence data and updated annotation of the genome of Agrobacterium tumefaciens C58, and distribution of a linear chromosome in the genus AgrobacteriumSteven Slater, João C Setubal, Brad Goodner, et al.
Kidney International|September 26, 2025
Strategies for the development of sodium-glucose cotransporter-2 inhibitors for kidney protection in pediatric chronic kidney disease: proceedings of a workshop meeting in July 2023William E Smoyer, Barbara S Gillespie, Louise Oni, et al.
Kidney International Reports|April 18, 2023
Pregnancy History and Kidney Disease Progression Among Women Enrolled in Cure GlomerulonephropathyMonica L Reynolds, Andrea L Oliverio, Jarcy Zee, et al.
American Journal of Nephrology|November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 StudiesCarla Nester, Gerald B Appel, Andrew S Bomback, et al.
Experimental Hematology & Oncology|August 23, 2025
Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibitionHayley M Sabol, Aric Anloague, Japneet Kaur, et al.
Pageof 62